Arda Therapeutics key facts
- Developer of transformative therapeutics designed to remove pathological cells, which are the root causes of chronic diseases.
- Arda Therapeutics’s last known valuation is $80.0M.
- It has raised $50.8M across 2 recorded rounds; the latest was Early Stage VC ($43.3M) in Sep 2024.
- Notable investors include Alumni Ventures, Andreessen Horowitz, Mana Ventures, Gaingels, GV — 20 tracked in total.
- Arda Therapeutics has filed 2 Form Ds with the SEC since 2022, most recently Oct 2024 ($43.3M sold to 17 investors).
- Status: Privately Held (backing).
Who backs Arda Therapeutics
20+Membership and data by Private Market View
- ·The complete investor list: 20 names
- ·Watch Arda Therapeutics: the Monday email on marks, rounds and moves
Arda Therapeutics funding rounds
2 roundsArda Therapeutics valuation
Arda Therapeutics's last known valuation is $80 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Arda Therapeutics raised?
Arda Therapeutics has raised $50.8 million across 2 recorded rounds since 2021. The largest was a $7.5 million early-stage round in Dec 2021; the most recent was a $43.3 million early-stage round in Sep 2024.
Arda Therapeutics has filed 2 Form Ds with the SEC since 2022, most recently in Oct 2024 ($43.3 million sold to 17 investors).
Arda Therapeutics investors
20 investors are on record for Arda Therapeutics, including Alumni Ventures, Andreessen Horowitz, Mana Ventures and Gaingels. By type, the record holds 9 venture capital firms. The early-stage round in Sep 2024 drew 17 investors.
About Arda Therapeutics
Developer of transformative therapeutics designed to remove pathological cells, which are the root causes of chronic diseases. The company first uses single-cell data from patients to identify which cells to target and how to target them, and then designs therapeutics to remove the entire pathological network that is the entire cell, enabling patients to get cured without affecting any cell other than their pathological cells.
- Sector
- Healthcare
- HQ
- San Carlos, CA, United States
- Founded
- 2021
- Employees
- 10
- Website
- ardatx.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Arda Therapeutics’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.